Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 40, Issue 4, 2005, Pages

  Vigouroux, Stéphane ^a   Morin, Odile ^a   Moreau, Philippe ^a   Méchinaud, Françoise ^a   Morineau, Nadine ^a   Mahé, Béatrice ^a   Chevallier, Patrice ^a   Guillaume, Thierry ^a   Dubruille, Viviane ^a   Harousseau, Jean Luc ^a   Milpied, Noël ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ABSIDIA; ADULT; ARTICLE; CASE REPORT; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MUCORMYCOSIS; PRESCHOOL CHILD; RHIZOMUCOR; RHIZOPUS; TIME; TREATMENT OUTCOME;

ABSIDIA; ADULT; ANTIFUNGAL AGENTS; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MUCORMYCOSIS; PYRIMIDINES; RHIZOMUCOR; RHIZOPUS; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES;

MLCS; MLOWN;

EID: 21844442741     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/427752     Document Type: Article

References (0)